Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|August 9, 2002
Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cellsSasha Lazetic, Steven R Leong, Jean C-C Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2003
Optimized expression and specific activity of IL-12 by directed molecular evolutionSteven R Leong, Jean C C Chang, Randal Ong, et al.
Mabs|October 7, 2022
Development of T-cell engagers selective for cells co-expressing two antigensDanielle M Dicara, Sunil Bhakta, Mary Ann Go, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2018
An Anti-CLL-1 Antibody-Drug Conjugate for the Treatment of Acute Myeloid LeukemiaBing Zheng, Shang-Fan Yu, Geoffrey Del Rosario, et al.
The Journal of Biological Chemistry|May 7, 2010
Development of a two-part strategy to identify a therapeutic human bispecific antibody that inhibits IgE receptor signalingJanet Jackman, Yongmei Chen, Arthur Huang, et al.
Blood|December 3, 2016
An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemiaSteven R Leong, Siddharth Sukumaran, Maria Hristopoulos, et al.
Molecular Pharmaceutics|April 9, 2015
An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancerSteven R Leong, Wei-Ching Liang, Yan Wu, et al.
The Journal of Clinical Investigation|May 12, 2010
Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized miceHans D Brightbill, Surinder Jeet, Zhonghua Lin, et al.
Molecular Cancer Therapeutics|April 1, 2022
Novel Anti-LY6G6D/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Colorectal CancerPeiyin Wang, Liping L Sun, Robyn Clark, et al.
Leukemia|January 10, 2022
A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myelomaSatoko Kakiuchi-Kiyota, Thorsten Ross, Heidi Ackerly Wallweber, et al.
Pageof 2